Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-25-110827
Filing Date
2025-11-13
Accepted
2025-11-13 07:00:58
Documents
55
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q clrb-20250930x10q.htm   iXBRL 10-Q 1424782
2 EX-31.1 clrb-20250930xex31d1.htm EX-31.1 11349
3 EX-31.2 clrb-20250930xex31d2.htm EX-31.2 11347
4 EX-32.1 clrb-20250930xex32d1.htm EX-32.1 9501
  Complete submission text file 0001104659-25-110827.txt   5843242

Data Files

Seq Description Document Type Size
5 EX-101.SCH clrb-20250930.xsd EX-101.SCH 39726
6 EX-101.CAL clrb-20250930_cal.xml EX-101.CAL 35484
7 EX-101.DEF clrb-20250930_def.xml EX-101.DEF 180724
8 EX-101.LAB clrb-20250930_lab.xml EX-101.LAB 309940
9 EX-101.PRE clrb-20250930_pre.xml EX-101.PRE 265667
58 EXTRACTED XBRL INSTANCE DOCUMENT clrb-20250930x10q_htm.xml XML 929632
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

EIN.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36598 | Film No.: 251475337
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)